1. Home
  2. SPKL vs CRVO Comparison

SPKL vs CRVO Comparison

Compare SPKL & CRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SPKL
  • CRVO
  • Stock Information
  • Founded
  • SPKL 2021
  • CRVO 2001
  • Country
  • SPKL United States
  • CRVO United States
  • Employees
  • SPKL N/A
  • CRVO N/A
  • Industry
  • SPKL
  • CRVO Biotechnology: Pharmaceutical Preparations
  • Sector
  • SPKL
  • CRVO Health Care
  • Exchange
  • SPKL Nasdaq
  • CRVO Nasdaq
  • Market Cap
  • SPKL 174.6M
  • CRVO 98.3M
  • IPO Year
  • SPKL 2023
  • CRVO N/A
  • Fundamental
  • Price
  • SPKL $10.66
  • CRVO $2.13
  • Analyst Decision
  • SPKL
  • CRVO Buy
  • Analyst Count
  • SPKL 0
  • CRVO 8
  • Target Price
  • SPKL N/A
  • CRVO $38.75
  • AVG Volume (30 Days)
  • SPKL 44.7K
  • CRVO 476.7K
  • Earning Date
  • SPKL 01-01-0001
  • CRVO 11-12-2024
  • Dividend Yield
  • SPKL N/A
  • CRVO N/A
  • EPS Growth
  • SPKL N/A
  • CRVO N/A
  • EPS
  • SPKL 0.19
  • CRVO N/A
  • Revenue
  • SPKL N/A
  • CRVO $10,066,550.00
  • Revenue This Year
  • SPKL N/A
  • CRVO $34.17
  • Revenue Next Year
  • SPKL N/A
  • CRVO N/A
  • P/E Ratio
  • SPKL $57.45
  • CRVO N/A
  • Revenue Growth
  • SPKL N/A
  • CRVO 116.29
  • 52 Week Low
  • SPKL $10.18
  • CRVO $1.80
  • 52 Week High
  • SPKL $11.95
  • CRVO $26.38
  • Technical
  • Relative Strength Index (RSI)
  • SPKL 61.06
  • CRVO 28.45
  • Support Level
  • SPKL $10.63
  • CRVO $1.99
  • Resistance Level
  • SPKL $10.66
  • CRVO $2.43
  • Average True Range (ATR)
  • SPKL 0.02
  • CRVO 0.17
  • MACD
  • SPKL 0.00
  • CRVO 0.31
  • Stochastic Oscillator
  • SPKL 75.00
  • CRVO 26.92

About SPKL Spark I Acquisition Corp.

Spark I Acquisition Corp is a Blank check company.

About CRVO CervoMed Inc.

CervoMed Inc is a clinical-stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.

Share on Social Networks: